JCT-208

N/A

Report date: 2022/10/21 17:09:40

Base Information

Drug NameJCT-208
Drug Alias NameJCT-208
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionWnt signalling pathway modulators
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale UniversityTranscenta Holding Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityTranscenta Holding Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A